D20170227
De-identified Human Immune Atlas donor/sample detail for HCC_GSE140228_Cell_2019. The record preserves available public metadata while avoiding direct identifiers.
Primary Metadata
Core de-identified metadata fields migrated from the ImmuneAging donor manifest.
Donor ID
D20170227
Sample ID
D20170227-Blood-CD45+, D20170227-Tumor-CD45+
Dataset
HCC_GSE140228_Cell_2019
Cohort
Chinese HCC immune-cell cohort, 10 donors
Age / Age Group
84 years
Sex
Female
Health Status
Hepatocellular carcinoma (HCC); HBV -; tumor stage IIIA
Tissue / Cell Source
blood; tumor tissue
Modality
scRNA-seq (Smart-seq2)
Cell Count
251
Analysis Status
Published scRNA-seq
UMAP Status
Ready
Metadata / Source Notes
Source patient ID: DSF27; Table S1 clinical characteristics: sex=Female, age=84 years, pathology=HCC, HBV=-, tumor stage=IIIA; Source: GEO GSE140228 processed metadata; PMID 31675496; platform: Smart-seq2; sample count: 2; tissues: Blood, Tumor; Donor UMAP PNG: IMG/umap/hcc-gse140228-cell-2019/donor/D20170227.png
Additional Clinical / Source Fields
Supplementary source metadata retained from the migrated manifest where available.
cancer type
Hepatocellular carcinoma
cancer type short
HCC
tnm stage
IIIA
bclc stage
Not provided
virus
HBV -
tumor size cm
Not provided
differentiation
Not provided
venous invasion
Not provided
cirrhosis
Not provided
afp ug l
Not provided
ca199 u ml
Not provided
cea ug l
Not provided
library count
2
library sample ids
D20170227-Blood-CD45+, D20170227-Tumor-CD45+
total reads
Not provided
source reference
Zhang et al., Cell 179, 829-845.e20 (2019), Table S1 and GSE140228
data accession
GSE140228; HRA000069
article url